-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
UNITED THERAPEUTICS Corp quarterly/annual Earnings Per Share, Diluted history and growth rate from 2010 to 2023.
- UNITED THERAPEUTICS Corp Earnings Per Share, Diluted for the quarter ending September 30, 2024 was 6.39 USD/shares, a 18.8% increase year-over-year.
- UNITED THERAPEUTICS Corp Earnings Per Share, Diluted for the twelve months ending September 30, 2024 was 22.7 USD/shares, a 25.4% increase year-over-year.
- UNITED THERAPEUTICS Corp annual Earnings Per Share, Diluted for 2023 was 19.8 USD/shares, a 32.1% increase from 2022.
- UNITED THERAPEUTICS Corp annual Earnings Per Share, Diluted for 2022 was 15 USD/shares, a 49.1% increase from 2021.
- UNITED THERAPEUTICS Corp annual Earnings Per Share, Diluted for 2021 was 10.1 USD/shares, a 12.8% decline from 2020.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)